APA (7th ed.) Citation

Thiemann, M., Oertel, S., Ehemann, V., Weichert, W., Stenzinger, A., Bischof, M., . . . Battmann, C. (2012). In vivo efficacy of the histone deacetylase inhibitor suberoylanilide hydroxamic acid in combination with radiotherapy in a malignant rhabdoid tumor mouse model. Radiation oncology, 7, . https://doi.org/10.1186/1748-717X-7-52

Chicago Style (17th ed.) Citation

Thiemann, Markus, et al. "In Vivo Efficacy of the Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid in Combination with Radiotherapy in a Malignant Rhabdoid Tumor Mouse Model." Radiation Oncology 7 (2012). https://doi.org/10.1186/1748-717X-7-52.

MLA (9th ed.) Citation

Thiemann, Markus, et al. "In Vivo Efficacy of the Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid in Combination with Radiotherapy in a Malignant Rhabdoid Tumor Mouse Model." Radiation Oncology, vol. 7, 2012, https://doi.org/10.1186/1748-717X-7-52.